Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate.

  • Authors : Lin S; Department of Severe Hepatopathy, Mengchao Hepatobiliary Hospital of Fujian Medical University, No.66 Jintang Road, Jianxin Town, Cangshan District, Fuzhou, 350028, Fujian Province, China.; Huang W

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: Scientific reports [Sci Rep] 2024 Nov 09; Vol. 14 (1), pp. 27369. Date of Electronic Publication: 2024 Nov 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

  • Authors : Merchant E; Department of Medicine, Tufts Medical Center, Boston, MA, United States of America.; Tufts University School of Medicine, Boston, MA, United States of America.

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: PloS one [PLoS One] 2024 Dec 05; Vol. 19 (12), pp. e0311591. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

  • Authors : Lee SY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan.; Lin YC

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Pyridones*/Pyridones*/Pyridones*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Nov 20; Vol. 19 (11), pp. e0314003. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa.

  • Authors : Reddy K; Department of Paediatrics and Child Health, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.; Naidoo KL

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Nov; Vol. 27 (11), pp. e26379.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta-analysis.

  • Authors : Yoo JJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.; Jung EA

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/adverse effects

  • Source: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Sep; Vol. 27 (9), pp. e26358.Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B.

  • Authors : Cao F; Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, No. 321 Zhongshan Road, Nanjing, Jiangsu, 210008, China.; Fan T

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy

  • Source: Virology journal [Virol J] 2024 Sep 28; Vol. 21 (1), pp. 234. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

تفاصيل العنوان

×
Academic Journal

Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study.

  • Authors : Zeng QL; Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. .; Chen RY

Subjects: Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use ; Tenofovir*/Tenofovir*/Tenofovir*/administration & dosage ; Tenofovir*/Tenofovir*/Tenofovir*/analogs & derivatives

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 15; Vol. 24 (1), pp. 830. Date of Electronic Publication: 2024 Aug 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis.

  • Authors : Long J; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.; Saw M

Subjects: Dysbiosis*/Dysbiosis*/Dysbiosis*/microbiology ; Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/Gastrointestinal Microbiome*/drug effects ; Tenofovir*/Tenofovir*/Tenofovir*/therapeutic use

  • Source: BMC microbiology [BMC Microbiol] 2024 Sep 20; Vol. 24 (1), pp. 359. Date of Electronic Publication: 2024 Sep 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

تفاصيل العنوان

×
Academic Journal

Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.

  • Authors : Barroso S; Inherited Metabolic Diseases and Muscular Disorders Research Lab, Cellex-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine and Health Sciences, University of Barcelona (UB), 08036 Barcelona, Spain.; Department of Internal Medicine, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/metabolism ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 01; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

×
Academic Journal

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

  • Authors : Ismael N; Instituto Nacional de Saúde, EN1, Bairro da Vila - Parcela N˚3943, Marracuene Sede, Marracuene, Maputo Province, Mozambique. .; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. .

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV Infections*/HIV Infections*/HIV Infections*/virology ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 29; Vol. 24 (1), pp. 748. Date of Electronic Publication: 2024 Jul 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
  • 1-10 ل  7,486 نتائج ل ""Tenofovir""